Investigational drug · Phase 2
EMP-01
Not approved by FDA. In 1 industry-sponsored Phase 2 or 3 trial that is active or finished in the last two years, most often for Social Anxiety Disorder.
Phase 2Last checked: Nov 19, 2026Latest source record: Jul 31, 2026 (newest trial update)Source: ClinicalTrials.govMethods & limitations
Highest phase
Phase 2
Industry-sponsored trials
Phase 2 and 3 trials
1
0 still active
All registered trials
1
Any phase or sponsor naming "EMP-01"
First trial start
2025
May 8, 2025
Sponsors
Lead sponsors of its Phase 2 and 3 trials.
All registered trials by phase
Every ClinicalTrials.gov drug study naming "EMP-01", any sponsor or status.
Conditions studied
As listed on its trial records.
- Social Anxiety Disorder
Approved drugs for the same conditions: Anxiety disorders · Psychiatry
Largest trials
Live from ClinicalTrials.gov: studies naming "EMP-01" as an intervention, largest first.
atai Therapeutics, Inc.Industry
NCT06693609 · 70 participants · Start May 8, 2025 · Primary completion Dec 10, 2025
Drug: EMP-01; EMP-01 Placebo · For: Social Anxiety Disorder
Sites: Bridgetown, United Kingdom; Manchester, United Kingdom; Blackpool, United Kingdom · 7 sites in all
Newest research
PubMed records naming it or its code names, newest first.
No PubMed records name it yet, which is common for early code-named drugs.
Also in development for Social Anxiety Disorder
- FasedienolPhase 32 trials
VistaGen Therapeutics, Inc. · Social Anxiety Disorder, Social Anxiety Disorder (SAD)
- BNC210Phase 31 trial
Bionomics Limited · Social Anxiety Disorder
- RGH-202Phase 21 trial
Gedeon Richter Plc. · Social Anxiety Disorder
Names are merged from how sponsors list this drug on ClinicalTrials.gov, so an alias can occasionally belong to a related compound. Development status changes faster than registry records do.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.